Forsiden ENOVA

Group photo from 2nd enova workshop

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)

News

  • Adjuvants - the unsung heroes of vaccines Sep. 17, 2021 9:39 AM

    Article by ENOVA member Anita Milicic about the history of adjuvants

  • Virtual Networking Grants May 21, 2021 10:58 AM

    COST has launched Virtual Networking Support and there are two options available:

  • live_logo LIVE Master in Vaccinology Dec. 2, 2020 11:22 AM

    Leading Interational Vaccinology Education

    A Programme of Excellence in Learning and Research, Looking for Biochemists, Bioengineers, Biologists, Clinicians, Pharmacists and Veterinarians

  • transvac2-tna2010-10-social-media-banner Transvac call Nov. 6, 2020 11:58 AM

    Open Call: Apply for TRANSVAC2 Vaccine Development Services

Events

20 Sep.
Genova Italy

This workshop was planned for 23-25 March 2020, but due to COVID-19 pandemic have been moved to a hybrid (online-physical) at the same place but new time point: 20-22 september 2021.

 

The next ENOVA workshop will held in Genova, ITALY. Beside the administrative meetings, such as MC meeting or networking activity, there will be one keynote presentation (Vaccine-controlled infective diseases and cancer burden: achievements and perspectives, Prof. Alberto Izzotti, Genova University) and five scientific sessions (Improving existing adjuvant-based formulations; Novel vaccine adjuvants; Scale-up procedures for adjuvant production; Assays for the characterization of antigen-adjuvant formulations, and Selecting protocols for preclinical testing and down selection).

21 Sep.
Genova Italy

This workshop was planned for 23-25 March 2020, but due to COVID-19 pandemic have been moved to a hybrid (online-physical) at the same place but new time point: 20-22 september 2021.

 

The next ENOVA workshop will held in Genova, ITALY. Beside the administrative meetings, such as MC meeting or networking activity, there will be one keynote presentation (Vaccine-controlled infective diseases and cancer burden: achievements and perspectives, Prof. Alberto Izzotti, Genova University) and five scientific sessions (Improving existing adjuvant-based formulations; Novel vaccine adjuvants; Scale-up procedures for adjuvant production; Assays for the characterization of antigen-adjuvant formulations, and Selecting protocols for preclinical testing and down selection).

22 Sep.
Genova Italy

This workshop was planned for 23-25 March 2020, but due to COVID-19 pandemic have been moved to a hybrid (online-physical) at the same place but new time point: 20-22 september 2021.

 

The next ENOVA workshop will held in Genova, ITALY. Beside the administrative meetings, such as MC meeting or networking activity, there will be one keynote presentation (Vaccine-controlled infective diseases and cancer burden: achievements and perspectives, Prof. Alberto Izzotti, Genova University) and five scientific sessions (Improving existing adjuvant-based formulations; Novel vaccine adjuvants; Scale-up procedures for adjuvant production; Assays for the characterization of antigen-adjuvant formulations, and Selecting protocols for preclinical testing and down selection).